In addition to B7-H1, human ovarian cancer and cancer-associated myeloid antigen-presenting cells also express high levels of B7-H4 (B7x, B7s1), which are negatively associated with patient survival [74, 80, 81]. This evidence concerns the gene VTCN1 and cancer.